Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 38 - Medicinal preparations containing peptides
Patents for A61K 38 - Medicinal preparations containing peptides (316,240)
09/2010
09/02/2010US20100222264 Use of rgd-enriched gelatine-like proteins for inhibition of cancer metastasis
09/02/2010US20100222263 Atap peptides, nucleic acids encoding the same and associated methods of use
09/02/2010US20100222262 Substituted 1, 3-cyclopentadione attenuated endothelial inflammation and endothelial-monocyte interactions
09/02/2010US20100222261 Peptidic antagonists of class iii semaphorins/neuropilins complexes
09/02/2010US20100222260 Uses of pegylated albumin
09/02/2010US20100222259 Compositions for enhancing the production of PPAR and/or PPAR-associated factors
09/02/2010US20100222258 TNF antagonist and TNF inhibitor containing it as an effective ingredient
09/02/2010US20100222257 Substituted phenethylamines
09/02/2010US20100222256 Novel polypeptide anti-HIV agent containing the same
09/02/2010US20100222255 Peptoid oligomers, pharmaceutical compositions and methods of using the same
09/02/2010US20100222254 Stabilization of clostridium botulinum neurotoxin complex
09/02/2010US20100222253 Methods for extracting platelets and compositions obtained therefrom
09/02/2010US20100222252 Deshydroxy vancomycin, the preparation, pharmaceutical composition and the use
09/02/2010US20100222251 Mixture comprising an amylin peptide and a protracted insulin
09/02/2010US20100222250 Poly-beta-peptides from functionalized beta-lactam monomers and antibacterial compositions containing same
09/02/2010US20100222237 Methods for Generating Polynucleotides Having Desired Characteristics by Iterative Selection and Recombination
09/02/2010US20100221822 Humanized and chimeric antibodies specific for lipoteichoic acid of gram positive bacteria
09/02/2010US20100221782 Modified Chimeric Polypeptides With Improved Pharmacokinetic Properties
09/02/2010US20100221779 Phytases, nucleic acids encoding them and methods for making and using them
09/02/2010US20100221753 Prostate Cancer-Related Compositions, Methods and Kits Based on DNA Macroarray Proteomics Platforms
09/02/2010US20100221746 Compositions and methods for the treatment of disease
09/02/2010US20100221743 Methods for Diagnosing and Treating Endoplasmic Reticulum (ER) Stress Diseases
09/02/2010US20100221731 Methods for assessing MetAP2 Resistance, Disease Progression, and Treatment Efficacy in Ovarian Cancer
09/02/2010US20100221730 Methods for assessing SPARC Resistance, Disease Progression, and Treatment Efficacy in Ovarian Cancer
09/02/2010US20100221729 Methods for assessing Calpain 2 Resistance, Disease Progression, and Treatment Efficacy in Ovarian Cancer
09/02/2010US20100221720 Plant artificial chromosomes, uses thereof and methods of preparing plant artificial chromosomes
09/02/2010US20100221372 Wolfberries and skin inflammation
09/02/2010US20100221359 Solid Compositions Containing Combinations of Lactoferrin, Colostrm, and Citrus Pectin
09/02/2010US20100221351 Controlled Drug Delivery Using a Thermally Responsive Nanocapsule to Augment Cryoablation
09/02/2010US20100221345 Osteogenic biomaterial containing osteogenesis promoting substance and nanogel
09/02/2010US20100221343 Compositions and methods of making brittle-matrix particles through blister pack freezing
09/02/2010US20100221329 Formulations of guanylate cyclase c agonists and methods of use
09/02/2010US20100221319 Compositions and Methods for Improved Skin Care
09/02/2010US20100221318 Nucleic acids for inhibiting hairless protein expression and methods of use thereof
09/02/2010US20100221317 Dynamin mediated diseases and associated methods and products
09/02/2010US20100221314 Microneedle Device
09/02/2010US20100221310 Medical products including modified extracellular matrix materials
09/02/2010US20100221308 Antimicrobial compositions and uses thereof
09/02/2010US20100221305 Formulations for coated microprojections containing non-volatile counterions
09/02/2010US20100221302 Delivery System For Heparin-Binding Growth Factors
09/02/2010US20100221300 Processing of Angiogenic Scaffolds for Large Organ Regeneration
09/02/2010US20100221299 Therapeutic stem cell nutrient composition and uses thereof
09/02/2010US20100221295 Cosmetic use of whey protein micelles
09/02/2010US20100221291 Collagen tubes
09/02/2010US20100221288 Novel streptococcus pneumoniae open reading frames encoding polypeptide antigens and uses thereof
09/02/2010US20100221287 Streptococcus pneumoniae Polynucleotides and Sequences
09/02/2010US20100221274 Method of administering a thymosin alpha 1 peptide
09/02/2010US20100221273 Treatment of viral infections
09/02/2010US20100221269 Synthetic lipid a derivative
09/02/2010US20100221266 Methods to regulate mirna processing by targeting lin-28
09/02/2010US20100221265 Immune modulation via c-type lectin
09/02/2010US20100221264 Inhibition of HIV-1 Replication by Disruption of the Processing of the Viral Capsid-Spacer Peptide 1 Protein
09/02/2010US20100221261 Iap bir domain binding compounds
09/02/2010US20100221255 Apelin peptides and methods of use
09/02/2010US20100221252 Mdl-1 uses
09/02/2010US20100221251 Compositions and Methods for Treatment of Cancer
09/02/2010US20100221249 Wisp polypeptides and nucleic acids encoding same
09/02/2010US20100221247 Agents and methods for treatment of cancer
09/02/2010US20100221245 Topical skin care composition
09/02/2010US20100221242 Anti-viral griffithsin compounds, compositions and methods of use
09/02/2010US20100221240 Chemically Modified Peptide Analogs
09/02/2010US20100221237 Enzyme disruption of bacterial biofilms
09/02/2010US20100221236 Mutants of Staphylokinase Carrying Amino and Carboxy-Terminal Extensions for Polyethylene Glycol Conjugation
09/02/2010US20100221235 Compositions and Methods for Treating Lysosomal Storage Diseases
09/02/2010US20100221234 Bone delivery conjugates and method of using same to target proteins to bone
09/02/2010US20100221229 Modulating bone growth in treating scoliosis
09/02/2010US20100221227 Novel method of treating disease
09/02/2010US20100221224 Composition and method for self-assembly and mineralization of peptide-amphiphiles
09/02/2010US20100221223 Immune response induction method
09/02/2010US20100221222 Interferons, uses and compositions related thereto
09/02/2010US20100221221 N-phenyl-2-pyrimidineamine derivatives
09/02/2010US20100221220 Therapeutics for cancer using 3-bromopyruvate and other selective inhibitors of atp production
09/02/2010US20100221219 Compositions for treating multiple sclerosis
09/02/2010US20100221218 Methods for the identification of agents that inhibit mesenchymal-like tumor cells or their formation
09/02/2010US20100221217 Therapeutic composition
09/02/2010US20100221216 Hepatitis c virus inhibitors
09/02/2010US20100221215 Linked dibenzimidazole derivatives
09/02/2010US20100221214 Linked dibenzimidazole derivatives
09/02/2010US20100221213 Y-shape branched hydrophilic polymer derivatives, their preparation methods, conjugates of the derivatives and drug molecules, and pharmaceutical compositions comprising the conjugates
09/02/2010US20100221212 Proproteins and methods of use thereof
09/02/2010US20100221211 Pyridone-substituted-dihydropyrazolopyrimidinone derivative
09/02/2010US20100221210 Dimeric Alpha Interferon PEGylated Site-Specifically Shows Enhanced and Prolonged Efficacy in Vivo
09/02/2010US20100221209 Use of Cytokines and Mitogens to Inhibit Pathological Immune Responses
09/02/2010US20100221208 Treatment and Diagnostic Methods for Fibrosis Related Disorders
09/02/2010US20100221179 IL-1 Binding Proteins
09/02/2010US20100221177 RS7 Antibodies
09/02/2010US20100221175 Antibody Therapy
09/02/2010CA2790791A1 Use of guanylyl cyclase c agonists to suppress appetite
09/02/2010CA2789941A1 Infertility associated defb-126 deletion polymorphism
09/02/2010CA2753884A1 Soft protease inhibitors, and pro-soft forms thereof
09/02/2010CA2753827A1 Apparatus, system, and method for creating immunologically enhanced spaces in-vivo
09/02/2010CA2753804A1 Compositions and methods for visualizing and eliminating cancer stem cells
09/02/2010CA2753139A1 Drug delivery management systems and methods
09/02/2010CA2752891A1 Peptidomimetic cyclic compounds for treating retinitis pigmentosa
09/02/2010CA2752647A1 Designer ligands of tgf-beta superfamily
09/02/2010CA2751156A1 Visfatin therapeutic agents for the treatment of acne and other conditions
09/01/2010EP2224012A1 Compositions and methods for the therapy and diagnosis of inflammatory bowel disease
09/01/2010EP2224003A2 MicroRNA molecules
09/01/2010EP2224002A1 Np1 activity regulating elements which can be used in the production of drugs for the treatment or prevention of human neurodegenerative diseases, resulting drugs and use thereof
09/01/2010EP2224001A1 Improved epitope displaying phage
1 ... 588 589 590 591 592 593 594 595 596 597 598 599 600 601 602 603 604 605 606 607 608 ... 3163